Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Oct;35(7):613-623.
doi: 10.1007/s10585-018-9932-8. Epub 2018 Aug 22.

Black race and distant recurrence after neoadjuvant or adjuvant chemotherapy in breast cancer

Jessica M Pastoriza  1   2   3 , George S Karagiannis  2   4   3 , Juan Lin  5 , Sonali Lanjewar  6 , David Entenberg  2   4   3 , John S Condeelis  2   4   3 , Joseph A Sparano  7 , Xiaonan Xue  5 , Thomas E Rohan  5 , Maja H Oktay  8   9   10   11   12
Affiliations

Black race and distant recurrence after neoadjuvant or adjuvant chemotherapy in breast cancer

Jessica M Pastoriza et al. Clin Exp Metastasis. 2018 Oct.

Abstract

Black race compared to white race is associated with more advanced stage and biologically aggressive breast cancer. Consequently, black patients are more frequently treated with neoadjuvant chemotherapy (NAC) than white patients. However, it is unclear how distant recurrence-free survival (DRFS) of black patients treated with NAC, compares to DRFS of black patients treated with adjuvant chemotherapy (AC). We evaluated the association between race, distant recurrence, and type of chemotherapy (AC or NAC) in localized or locally advanced breast cancer. We evaluated DRFS in 807 patients, including 473 black, 252 white, 56 Hispanic, and 26 women of other or mixed race. The association between AC or NAC and DRFS was examined using multivariate Cox proportional hazard models that included race, age, stage, estrogen receptor (ER) and triple negative (TN) status. When the black and white subjects were pooled for the analysis the features associated with worse DRFS included stage III disease and age < 50 years, but not ER-negative disease, TN disease, the use of NAC, or black race. However, in the analysis stratified by race NAC was associated with worse DRFS compared to AC in black (HR 2.70; 95% CI 1.73-4.22; p < 0.0001), but not in white women (HR 1.29, 95% CI 0.56-2.95; p = 0.36). Black patients treated with NAC had worse DRFS than black patients treated with AC, or white patients treated with either NAC or AC. These findings need to be validated in a large-scale observational study and the effect of NAC on the breast cancer microenvironment in black women needs to be further evaluated.

Keywords: Adjuvant chemotherapy; Black patients; Breast cancer; Distant recurrence; Neoadjuvant chemotherapy.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The authors have declared no conflicts of interest.

Figures

Figure 1.
Figure 1.
Consort diagram.
Figure 2.
Figure 2.
(A-B) Kaplan-Meier curves demonstrating distant recurrence-free survival (DRFS) in black and white patients treated with either neoadjuvant (NAC) or adjuvant (AC) chemotherapy (A, non-stratified analysis; B, analysis stratified according to race and treatment). (C-D) KaplanMeier curves demonstrating DRFS in patients of various racial ethnicities, all treated with NAC. (C, race and ethnicity separated; D, DRFS for black vs. non-black races and ethnicities pooled).
See this image and copyright information in PMC

References

    1. N H, AM N, M K, D M, K B, CL K, M Y, J R, Z T, A M, DR L, HS C, EJ F, KA C (2017) SEER Cancer Statistics Review, 1975–2014, National Cancer Institute; Bethesda, MD.
    1. Eley JW, Hill HA, Chen VW, Austin DF, Wesley MN, Muss HB, Greenberg RS, Coates RJ, Correa P, Redmond CK, et al. (1994) Racial differences in survival from breast cancer. Results of the National Cancer Institute Black/White Cancer Survival Study. JAMA 272 (12):947–954 - PubMed
    1. Chu KC, Lamar CA, Freeman HP (2003) Racial disparities in breast carcinoma survival rates: seperating factors that affect diagnosis from factors that affect treatment. Cancer 97 (11):2853–2860. doi:10.1002/cncr.11411 - DOI - PubMed
    1. Li CI, Malone KE, Daling JR (2002) Differences in breast cancer hormone receptor status and histology by race and ethnicity among women 50 years of age and older. Cancer Epidemiol Biomarkers Prev 11 (7):601–607 - PubMed
    1. Elledge RM, Clark GM, Chamness GC, Osborne CK (1994) Tumor biologic factors and breast cancer prognosis among white, Hispanic, and black women in the United States. Journal of the National Cancer Institute 86 (9):705–712 - PubMed

Publication types

LinkOut - more resources